SYSTEMATIC REVIEW
Published on 24 Mar 2025
Olaparib monotherapy or combination therapy in lung cancer: an updated systematic review and meta- analysis
doi 10.3389/fonc.2025.1505889
- 356 views
- Frontiers in Oncology
- Molecular and Cellular Oncology
- Research Topics
- Repurposed Drugs Targeting Cancer Signaling Pathways: Clinical Insights to Improve Oncologic Therapies Volume II
Repurposed Drugs Targeting Cancer Signaling Pathways: Clinical Insights to Improve Oncologic Therapies Volume II
5,112
Total downloads
17k
Total views and downloads
Articles
REVIEW
Published on 21 Mar 2025
Repurposing alternative splicing events as potential targets for the design of diagnostic and therapeutic tools in PCa
doi 10.3389/fonc.2025.1520985
- 168 views
REVIEW
Published on 14 Jan 2025
Revolutionizing ovarian cancer therapy by drug repositioning for accelerated and cost-effective treatments
doi 10.3389/fonc.2024.1514120
- 1,002 views
BRIEF RESEARCH REPORT
Published on 15 Nov 2024
Repurposing of PSMA-targeted diagnostic and therapeutic agents for the detection and treatment of giant cell tumors of bone
doi 10.3389/fonc.2024.1504514
- 833 views
- 1 citation
REVIEW
Published on 08 Oct 2024
Challenges and advances in glioblastoma targeted therapy: the promise of drug repurposing and biomarker exploration
doi 10.3389/fonc.2024.1441460
- 1,793 views
- 2 citations
ORIGINAL RESEARCH
Published on 22 May 2024
Age-dependent molecular variations in osteosarcoma: implications for precision oncology across pediatric, adolescent, and adult patients
doi 10.3389/fonc.2024.1382276
- 1,309 views
- 2 citations
MINI REVIEW
Published on 08 May 2024
Drug repositioning in thyroid cancer: from point mutations to gene fusions
doi 10.3389/fonc.2024.1407511
- 1,105 views
ORIGINAL RESEARCH
Published on 20 Mar 2024
Antineoplastic effect of compounds C14 and P8 on TNBC and radioresistant TNBC cells by stabilizing the K-Ras4BG13D/PDE6δ complex
doi 10.3389/fonc.2024.1341766
- 1,862 views
ORIGINAL RESEARCH
Published on 16 Feb 2024
National expert consensus on home-administered oncologic therapies in Spain
doi 10.3389/fonc.2024.1335344
- 2,554 views
- 2 citations
ORIGINAL RESEARCH
Published on 05 Jan 2024
Sulconazole inhibits PD-1 expression in immune cells and cancer cells malignant phenotype through NF-κB and calcium activity repression
doi 10.3389/fimmu.2023.1278630
- 2,204 views
